Women & Infants Hospital-Pathology Faculty Update

Tip Pongsuvareeyakul, MD, has completed her 9-month International Visiting Fellowship in Gynecologic Pathology.She has returned to Chiang-Mai University College of Medicine as Assistant Professor of Pathology in July.

Janell A. Carter, MD, PhD, has completed her 2-year pathology research fellowship sponsored by Brown University Department of Pathology & Laboratory Medicine. She was recruited to be the inaugural Division Director of Perinatal Pathology of Phoenix Children’s Hospital in Phoenix, Arizona.

Providence VA Hospital-Pathology Faculty Update

Bassam Aswad, MD, Assistant Professor of Pathology and Laboratory Medicine, Clinician Educator and Dongfen Chen, MD, Instructor in Pathology and Laboratory Medicine, Clinician Educator have been appointed to the faculty at the Providence VA Medical Center.

Commentary in Hematology/Oncology by Dr. Wafik El-Deiry at the Annual American Society for Clinical Oncology (ASCO) Meeting

Commentary in Hematology/Oncology on "Liquid biopsy can direct use of EGFR rechallenge in metastatic colorectal cancer," a study presented at the 2021 annual American Society for Clinical Oncology (ASCO) meeting.

Commentary in Hematology/Oncology on "Alrizomadlin may restore efficacy of PD-1 blockade in immunotherapy-resistant tumors," a study presented at the 2021 annual American Society for Clinical Oncology (ASCO) meeting.

 

Elizabeth Arslanian, MD Joins the Pathology Faculty

Dr. Elizabeth Arslanian has joined the Pathology faculty as an Instructor (Research) and will be working in Dr. El-Deiry's lab.  Dr. Arslanian received her MD from the University of Montreal in 2016 and completed her postdoctoral training in Anatomical Pathology in 2021.

 

Douglas Anthony, MD, PhD installed as Vice President-Elect of the American Association of Neuropathologists (AANP)

Dr. Douglas Anthony, Professor of Pathology and Laboratory Medicine, Professor of Neurology and Chief of Pathology at The Miriam Hospital and Rhode Island Hospital was installed as Vice President-Elect of the American Association of Neuropathologists (AANP) at their annual meeting in St. Louis.  In addition, Dr. Anthony has been serving as the Vice President of the International Society since 2018. He is scheduled to become President of the AANP in 2024, and preside over the annual meeting in 2025.

Wafik S. El-Deiry, MD, PhD, FACP Voted on Larvol View as One of the Top 100 Most Influential Oncologists on Twitter 2021

Wafik S. El-Deiry, MD, PhD, FACP has been ranked at #6 on the LARVOL VIEW Top 100 list of the most influential Digital Opinion Leaders (DOLs) in oncology on Twitter.

LARVOL's methodology selects and ranks DOLs based on online influence, offline activity, and the opinions of other verified oncologists. Top oncologists are turning to Twitter for important conversations with their peers. In fact, there are almost 500 tweets every week posted by verified oncologists related to trending news in cancer research, trials, treatments, and drug development. This trend is growing, and a group of over 1,200 Digital Opinion Leaders (DOLs) has emerged as an important voice in the community.  Today, LARVOL recognizes the leading voices among DOLs with the 2021 LARVOL VIEW Top 100 Most Influential Oncologists on Twitter. This curated list represents the 100 oncologists with the largest influence on the cancer conversation on Twitter, balanced with analysis of their offline activity in the field and the input of their peers.  The 100 oncologists on the list stand out as those who are leading the way online and taking advantage of the full potential of Twitter as a tool to educate and inspire their peers, and the medical community.

How was this list developed?

To identify voices of influence on Twitter, the LARVOL team started by tracking oncology news on Twitter, then built out a list of oncologists who were actively sharing and reacting to that news. LARVOL then implemented a weighted methodology to select and rank DOLs based on online influence, offline activity, and the opinions of other verified oncologists. Each score is weighted equally to produce the final LARVOL VIEW Top 100 ranking.

1. Online Rank: Measured by Twitter Followers and Reactions to oncology news (posts comments and quote tweets, as captured by VIEW)

2. Offline Rank: Measured by participation in ongoing Clinical Trials and Citations from the last 5 years (Google Scholar)

3. Peer Survey Rank: Nominations from peers in LARVOL VIEW Top 100 survey

The oncologists recognized on this year’s list were celebrated at LARVOL’s “Night at the Museum,” a unique event held in virtual reality on the final night of ASCO’s 2021 Virtual Meeting.  

The LARVOL VIEW Top 100 Most Influential Oncologists on Twitter is powered by VIEW, the first social listening and sentiment analysis platform focused on Twitter-verified oncologists, researchers, and DOLs. VIEW also presents a feed of curated oncology news from Twitter alongside the reactions of verified oncologists.  

Kamaljeet Singh, MD joins the Department of Pathology at Women & Infants Hospital

Dr. Kamaljeet Singh has joined the department as Associate Professor of Pathology & Laboratory Medicine of Brown University and Director of Breast Pathology and Associate Director of the Clinical Hematology Lab under the direction of Dr. James Sung, Chief of Pathology and Laboratory Medicine at Women & Infants Hospital.

Dr. Singh received his MD from the Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Science in India and completed his pathology residency training at the All India Institute of Medical Sciences.  Prior to beginning his training in the US, he had spent a year at the Johns Hopkins Hospital conducting research in ophthalmic pathology.  He completed his pathology residency training at Brown University and is board certified in anatomic pathology and clinical pathology.  He is breast fellowship trained at the Beth Israel Deaconess Medical Center.  Dr. Singh's specialties are in Breast Pathology and Gynecologic Pathology.  His clinical research interest is in diagnosis and prognostic markers for breast cancer.

 

 

Pages